¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"target lesions"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® target tissue ÇÑ±Û Ç¥ÀûÁ¶Á÷
¼³¸í   
  È£¸£¸ó¿¡ ´ëÇÏ¿© Ç¥ÀûÀÌ µÇ´Â ¼¼Æ÷¶ó´Â Àǹ̷μ­ ±× È£¸£¸ó¿¡ ´ëÇÑ ¼ö¿ëü¸¦ °¡Áö°í Àִ ¼¼Æ÷. ¿¹¸¦ µé¾î Àν¶¸°Àº Àν¶¸° ¼ö¿ëü¸¦ °¡Áø ¼¼Æ÷¸¦ Ç¥Àû¼¼Æ÷·Î ÇÏ¿© ÀÌ ¼¼Æ÷¿¡¸¸ ÀÛ¿ëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • source-target distance
    ¿øÃµÇ¥Àû»çÀ̰Ÿ®, ¿øÃµÇ¥Àû°£°Å¸®
  • target
    1. Ç¥Àû 2. Ç¥Àû¼¼Æ÷
  • target cell
    Ç¥Àû¼¼Æ÷
  • target cell anemia
    Ç¥Àû¼¼Æ÷ºóÇ÷
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • target gland
    Ç¥Àû»ù, Ç¥Àû¼±
  • target lesion
    Ç¥Àûº´ÅÍ
  • target organ
    Ç¥ÀûÀå±â
  • target population
    Ç¥ÀûÁý´Ü
  • target sign
    Ç¥Àû¡ÈÄ
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷
  • target organ
    Ç¥ÀûÀå±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸ºóÇ÷
  • clinical target volume
    ÀÓ»óÇ¥ÀûüÀû
  • target cell
    Ç¥Àû¼¼Æ÷
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • source-target distance
    ¼±¿øÇ¥Àû°£°Å¸®
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
  • target gland
    Ç¥Àû»ù
  • target lesion
    Ç¥Àûº´ÅÍ
  • target organ
    Ç¥ÀûÀå±â
  • planning target volume
    °èȹǥÀûºÎÇÇ
  • target population
    Ç¥ÀûÁý´Ü
  • target skin distance radiation
    Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
  • target sign
    Ç¥Àû¡ÈÄ
  • target
    Ç¥Àû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary vascular lesions
    ¿ø¹ß(¼º) Ç÷°ü°è º´º¯
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • fusional target
    À¶ÇÕÇ¥Áö
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • radiation,target theory of
    ¡­ÀÇ Ç¥ÀûÀÌ·Ð(¡­øöîÜìµÖå)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target lesions
    Ç¥Àûº´¼Ò, °ú³áº´¼Ò, ŸÄÉÆ®º´¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epileptogenic lesions
    °£Áú¾çº´º¯.
  • intestine, large,obstructive lesions
    ¼º º´º¯(øÍáðàõ ܻܨ)
  • primary vascular lesions
    ¿ø¹ß(¼º) Ç÷°ü°è º´º¯
  • skin lesions
    ÇǺκ´º¯(¡­Ü»Ü¨)
  • squamous intraepithelial lesions
    ÆíÆò¼¼Æ÷ »óÇdz»º´º¯
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • cell, target
    Ç¥Àû¼¼Æ÷
  • clinical target volume, CTV
    ÀÓ»óÇ¥ÀûüÀû
  • codocyte= target cell
    Ç¥Àû¼¼Æ÷
  • fusional target
    À¶ÇÕÇ¥Áö
  • leptocytes = target cell
    Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
  • maximum target dose
    ÃÖ°íÇ¥Àû¼±·®
  • mean target dose
    Æò±ÕÇ¥Àû¼±·®
  • median target absorbed dose
    Áß¾ÓÇ¥ÀûÈí¼ö¼±·®
  • median target dose
    Áß¾ÓÇ¥Àû¼±·®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷ (øöîÜá¬øà)
  • target molecular weight
    Ç¥ÀûºÐÀÚ·® (øöîÜÝÂí­Õá)
  • target organ
    Ç¥Àû±â°ü (øöîÜÐïί)
  • target sequence
    Ç¥Àû¼­¿­ (øöîÜßíÖª)
  • target theory
    Ç¥ÀûÀÌ·Ð (øöîÜ×âÖå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target
    Ç¥Àû, °ú³á
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • target organ
    Ç¥Àû±â°ü
  • target pattern
    °ú³á¾ç»ó
  • target sign
    °ú³á¡ÈÄ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FACES unique facies, anorexia, cachexia, and eye and skin lesions [syndrome]
CTV cervical and thoracic vertebrae; clinical target volume
DOTC Dameshek's oval target cell
FTAG, F-TAG fast-binding target-attaching globulin
MLTI mixed lymphocyte target interaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAL Coronary artery lesions
SOL Space Occupying Lesions
WML White matter lesions
CTV Clinical Target Volume
FRT FLP recognition target
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mean target dose
    Æò±Õ Ç¥Àû ¼±·®
  • projection target
    Åõ»ç Ç¥Àû
  • target
    ´ë»ó, Ç¥Àû, ¸ñÇ¥¹°
    1. ¾î¶² °ÍÀÌ ÇâÇÏ´Â ¸ñÀû¹° ¶Ç´Â Àå¼Ò. ¿¹ÄÁ´ë ¿¢½º¼± °ü¿¡ À־, ÀüÀÚ°¡ Ãæµ¹µÇ¾î ¿¢½º¼±À» ¹ßÇÏ´Â ±Ý¼Ó ¶Ç´Â ÆÇ°ú °°Àº °Í. 2. ¾î¶² Ư¼ö ¹°Áú
  • target cell
    Àû»ó ÀûÇ÷±¸, Ç¥Àû ÀûÇ÷±¸
    1. º´ÀûÀ¸·Î ¾ãÀº ÀûÇ÷±¸·Î¼­ ¿°»öÇÏ¸é ¾Ï»öÀÇ Á߽ɰú ±× µÑ·¹ÀÇ Çì¸ð±Û·Îºó °í¸®°¡, Çì¸ð±Û·ÎºóÀ» º°·Î ÇÔÀ¯ÇÏÁö ¾ÊÀº ´ã»ö ºñ¿°»ö ºÎºÐÀÇ È¯°ú ±¸º°µÇ¾î ³ªÅ¸³­´Ù. À̰ÍÀº ¼±Ãµ¼º, ÈÄõ¼º ºóÇ÷°ú °£Àå Áúȯ, ƯÈ÷ Æó¼â¼º Ȳ´Þ µîÀÇ Áúȯ¿¡¼­ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù. 2. È£¸£¸ó ȤÀº ¾à¹°°ú °°Àº Ư¼ö ¹°Áú¿¡ ÀÇÇÏ¿© ¼±ÅÃÀûÀ¸·Î ¿µÇâÀ» ¹Þ´Â ¼¼Æ÷. 3. NK ¼¼Æ÷, ¼¼Æ÷ µ¶¼º T ¼¼Æ÷, K ¼¼Æ÷ ¶Ç´Â ƯÀÌ Ç×ü¿¡ °ø°Ý ¸ñÇ¥°¡ µÇ´Â Ç׿ø º¸À¯ ¼¼Æ÷.
  • target lesion
    ¸ñÇ¥ º´¼Ò, Ç¥Àû º´¼Ò
  • target material
    Ÿ°Ù ¹°Áú
  • target organ
    Ç¥Àû ±â°ü
    È£¸£¸óÀÌ ±× Ư¼º¿¡ µû¶ó ¾î¶² ÀÏÁ¤ÇÑ Á¶Á÷À̳ª ±â°ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¶§ À̵é Á¶Á÷À̳ª ±â°üÀ» Ç¥Àû ±â°üÀ̶ó ÇÑ´Ù.
  • target sign
    °ú³á ¡ÈÄ
  • target type
    ¸ñÇ¥¹° ÇüÅÂ
  • target-object distance
    Ç¥Àû-ÇÇ»çü °Å¸®
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
target lesions of liver/spleen <radiology> Lymphosarcoma (including Kaposi sarcoma), melanoma
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ring lesions in brain <radiology> Hypodense, peripherally enhancing lesions, ** mnemonic: MAGIC DR., metastasis, abscess, glioma, granuloma, infarct, contusion, demyelination, resolving haematoma
(12 Dec 1998)
circumscribed breast lesions <radiology> Lucent, lipoma, oil cyst (following haematoma or biopsy), galactocele (associated with lactation), mixed density, fibro-adeno-lipoma, galactocele, intramammary lymph node, haematoma
(12 Dec 1998)
cold bone lesions <radiology> Overlying atenuation caused by pacemaker, barium, metal cross, wristwatch, radiation therapy, local vascular compromise, early osteomyelitis, tumour: neuroblastoma, renal cell carcinoma, thyroid carcinoma, anaplastic tumours (e.g. Reticulum cell sarcoma)
(12 Dec 1998)
polypoid gallbladder lesions <radiology> Cholesterol polyp, adenoma, papilloma (usually less than 1 cm, may be premalignant), carcinoma, metastasis, adenomyomatosis, tumefactive sludge, inflammatory polyp
(12 Dec 1998)
hot bone lesions <radiology> Non-routine localised hot bone lesions: Paget's disease, osteoid osteoma, fibrous dysplasia, melorheostosis generalised: hyperparathyroidism, haematologic disorders, Paget disease (rare), fibrous dysplasia, renal osteodystrophy
(12 Dec 1998)
skin lesions of tuberous sclerosis <radiology> Adenoma sebaceum, Shagreen patches, periungual fibromata, ash-leaf hypopigmentation
(12 Dec 1998)
stellate breast lesions <radiology> Scirrhous carcinoma (infiltrating ductal carcinoma), small (baby) scirrhous carcinoma, sclerosing ductal hyperplasia, traumatic fat necrosis, hyalinised fibroadenoma
(12 Dec 1998)
large breast lesions <radiology> Breast masses greater than 5 cm, lucent: lipoma, mixed lucent/opaque: fibro-adeno-lipoma, low-density opaque: giant fibroadenoma, cyst, cystosarcoma phylloides, mucinous carcinoma, high-density opaque (large and dense)
(12 Dec 1998)
large, dense breast lesions <radiology> Carcinoma, sarcoma, cystosarcoma phylloides, cyst, abscess, lymph nodes (lymphoma, leukaemia, metastasis)
(12 Dec 1998)
GI-tract target lesion <radiology> Metastatic melanoma, primary neoplasm, spindle cell tumour (benign or malignant), lymphoma, carcinoid, carcinoma, metastasis, breast carcinoma, lung carcinoma, renal carcinoma, Kaposi's sarcoma, eosinophilic granuloma, ectopic pancreas
(12 Dec 1998)
molybdenum target tube An X-ray tube with an anode surface made of molybdenum instead of tungsten, used in mammography.
(05 Mar 2000)
target 1. An object fixed as goal or point of examination.
2. In the ophthalmometer, the mire.
Synonym: target organ.
4. Anode of an X-ray tube.
See: X-ray.
Origin: It. Targhetta, a small shield
(05 Mar 2000)
target behaviour Operant in behaviour modification therapy, the prescribed behaviour.
(05 Mar 2000)
target cell An erythrocyte in target cell anaemia, with a dark centre surrounded by a light band that again is encircled by a darker ring; it thus resembles a shooting target; such cell's also appear after splenectomy.
A cell lysed by cytotoxic T lymphocytes, as in graft rejection.
Synonym: Mexican hat cell.
(05 Mar 2000)
target cell anaemia Any anaemia with a conspicuous number of target cells in the peripheral blood; characteristic of the thalassaemias and also found in several haemoglobinopathies.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target
    Ç¥Àû
  • target
    °ú³á;¸ñÇ¥;¸ñÇ¥¾×;hit a ~ °ú³á¿¡ ¸ÂÈ÷´Ù;¸ñÇ¥¾×¿¡ ´ÞÇÏ´Ù
  • target practice
    »ç°Ý¿¬½À
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á